Vaccine manufacturing is lumpy, supply not as good as hoped, UK says
Britain’s vaccine rollout is limited by a “lumpy” manufacturing process with production changes by Pfizer and a delay by AstraZeneca that could lead to brief supply disruption, Vaccine Deployment ...